Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Long-Term Risk of Reintervention After Surgical Leiomyoma Treatment in an Integrated Health Care System.
Obstet Gynecol. 2024 May 1;143(5):619-626. doi: 10.1097/AOG.0000000000005557. Epub 2024 Mar 28.
Obstet Gynecol. 2024.
PMID: 38547478
Free PMC article.
OBJECTIVE: To compare long-term risk of reintervention across four uterus-preserving surgical treatments for leiomyomas and to assess effect modification by sociodemographic factors in a prospective cohort study in an integrated health care delivery system. ...However, rat …
OBJECTIVE: To compare long-term risk of reintervention across four uterus-preserving surgical treatments for leiomyomas and to assess …
Intrauterine device, subdermal contraceptive, and depot medroxyprogesterone use among transmasculine and cisgender patients over a 10-year period.
Berglin M, Stram D, Stenquist A, Dessi S, Ritterman Weintraub M, Zaritsky E.
Berglin M, et al. Among authors: zaritsky e.
Contraception. 2022 Apr;108:56-60. doi: 10.1016/j.contraception.2021.11.001. Epub 2021 Nov 28.
Contraception. 2022.
PMID: 34848179
IMPLICATIONS: These findings suggest an improvement in use of long-term contraception and menstrual suppression medications for the transmasculine population. ...
IMPLICATIONS: These findings suggest an improvement in use of long-term contraception and menstrual suppression medications for the t …
Item in Clipboard
Cite
Cite